Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 7/20 | 0.80 |
| ▸ | RAB9A | P51151 | 5/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | ALPG | P10696 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | GFER | P55789 | 1/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.59 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12519753 | 1.00 | CHAT (0.80) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL3318878 | 0.89 | CHAT (1.00) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL9777568 | 0.89 | CHAT (1.00) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL12364526 | 0.87 | CHAT (0.64) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL12364525 | 0.87 | CHAT (0.64) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL19766254 | 0.86 | CHAT (0.62) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL16800098 | 0.86 | CHAT (0.62) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL13208385 | 0.85 | CHAT (0.61) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL12125135 | 0.85 | CHAT (0.61) | CHATRAB9AALDH1A1KDM4EHPGD | |
| SCHEMBL300426 | 0.85 | CHAT (0.61) | CHATRAB9AALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11697715-B2 | Cucurbituril-based hydrogels | SCHERMAN OREN (GB) | 2023-07-11 | — | — | US | disclosed |
| US-20200157294-A1 | STABLE WATER-BASED POLYMER EMULSIONS AND FIBER MODIFICATIONS FOR ENHANCED FIBER WETTING AND IMPREGNATION BASED ON CB[8] GUEST-HOST TECHNOLOGY | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-05-21 | — | — | US | disclosed |
| EP-2736962-B1 | SUPRAMOLECULAR CAPSULES | CAMBRIDGE ENTPR LTD (GB) | 2019-09-04 | — | — | EP | disclosed |
| WO-2018069516-A1 | CUCURBITURIL-BASED HYDROGELS | CAMBRIDGE ENTERPRISE LIMITED (GB/GB) (GB) | 2018-04-19 | — | — | WO | disclosed |
| US-20170211023-A1 | SUPRAMOLECULAR CAPSULES | AQDOT LTD (GB) | 2017-07-27 | — | — | US | disclosed |
| US-20170028374-A1 | SUPRAMOLECULAR CAPSULES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2017-02-02 | — | — | US | disclosed |
| US-9439868-B2 | Supramolecular capsules | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2016-09-13 | — | — | US | disclosed |
| EP-2222757-B1 | SUPRAMOLECULAR HANDCUFFS IN POLYMERIC ARCHITECTURE | CAMBRIDGE ENTPR LTD (GB) | 2016-09-07 | — | — | EP | disclosed |
| US-20150368407-A1 | NESTED SUPRAMOLECULAR CAPSULES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2015-12-24 | — | — | US | disclosed |
| US-20150110772-A1 | CUCURBITURIL-BASED HYDROGELS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2015-04-23 | — | — | US | disclosed |
| US-8757264-B2 | Viscous wellbore fluids | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2014-06-24 | — | — | US | disclosed |
| US-20140170214-A1 | SUPRAMOLECULAR CAPSULES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2014-06-19 | — | — | US | disclosed |
| US-20140113382-A1 | PLASMONIC JUNCTIONS FOR SURFACE-ENHANCED SPECTROSCOPY | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2014-04-24 | — | — | US | disclosed |
| US-8378059-B2 | Supramolecular handcuffs in polymeric architecture | CAMBRIDGE ENTERPRISE LTD. (GB) | 2013-02-19 | — | — | US | disclosed |
| WO-2012175900-A1 | PLASMONIC JUNCTIONS FOR SURFACE-ENHANCED SPECTROSCOPY | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2012-12-27 | — | — | WO | disclosed |
| US-20120103615-A1 | VISCOUS WELLBORE FLUIDS | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2012-05-03 | — | — | US | disclosed |
| US-20100247477-A1 | SUPRAMOLECULAR HANDCUFFS IN POLYMERIC ARCHITECTURE | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-09-30 | — | — | US | disclosed |
| WO-2009071899-A2 | SUPRAMOLECULAR HANDCUFFS IN POLYMERIC ARCHITECTURE | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2009-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247477-A1 | SUPRAMOLECULAR HANDCUFFS IN POLYMERIC ARCHITECTURE | CCR8, BIRC8, CBX8 | CHAT 2733/4885RAB9A 3662/4885ALDH1A1 2358/4885 |
| US-20140170214-A1 | SUPRAMOLECULAR CAPSULES | TBCB, NOD2, ICOSLG | CHAT 1947/4885RAB9A 3299/4885ALDH1A1 3273/4885 |
| US-20150110772-A1 | CUCURBITURIL-BASED HYDROGELS | JAK1, SHH, NOD2 | CHAT 3125/4885RAB9A 3409/4885ALDH1A1 1903/4885 |
| US-11697715-B2 | Cucurbituril-based hydrogels | SMARCA5, CMBL, MGLL | CHAT 1956/4885RAB9A 4450/4885ALDH1A1 2145/4885 |
| US-20170028374-A1 | SUPRAMOLECULAR CAPSULES | TBCB, NOD2, ICOSLG | CHAT 1947/4885RAB9A 3299/4885ALDH1A1 3273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.